{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:29:11Z","timestamp":1786548551227,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/ajg.2009.596","type":"journal-article","created":{"date-parts":[[2009,10,27]],"date-time":"2009-10-27T11:49:19Z","timestamp":1256644159000},"page":"125-131","source":"Crossref","is-referenced-by-count":72,"title":["PML Nuclear Body Component Sp140 Is a Novel Autoantigen in Primary Biliary Cirrhosis"],"prefix":"10.14309","volume":"105","author":[{"given":"Alessandro","family":"Granito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Quarneti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco B","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald B","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Muratori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-3-1","article-title":"Primary biliary cirrhosis.","volume":"3","author":"Kumagi","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"R3-22-20210210","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1542-3565(04)00465-3","article-title":"Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?","volume":"2","author":"Yang","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-22-20210210","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/gut.2003.036558","article-title":"DE, Pares A, Zachou K et al. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis.","volume":"54","author":"Rigopoulou","year":"2005","journal-title":"Gut"},{"key":"R5-22-20210210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1568-9972(03)00013-2","article-title":"CJ. Antinuclear antibodies specific for primary biliary cirrhosis.","volume":"2","author":"Worman","year":"2003","journal-title":"Autoimmun Rev"},{"key":"R6-22-20210210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1365-2249.2002.01719.x","article-title":"Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders.","volume":"127","author":"Muratori","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"R7-22-20210210","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1365-2036.2006.03172.x","article-title":"Antinuclear antibodies giving the multiple nuclear dots or the rim-likemembranous patterns: diagnostic accuracy for primary biliary cirrhosis.","volume":"24","author":"Granito","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R8-22-20210210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2007-1007184","article-title":"Autoantibodies against nuclear dots in primary biliary cirrhosis.","volume":"17","author":"Szostecki","year":"1997","journal-title":"Semin Liver Dis"},{"key":"R9-22-20210210","first-page":"108","article-title":"Autoimmune sera recognize a 100kD nuclear protein antigen (sp-100).","volume":"68","author":"Szostecki","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"R10-22-20210210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-3083.1995.tb03652.x","article-title":"Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis.","volume":"42","author":"Sternsdorf","year":"1995","journal-title":"Scand J Immunol"},{"key":"R11-22-20210210","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.20619","article-title":"Small ubiquitin-related modifiers: a novel and independent class of autoantigens in primary biliary cirrhosis.","volume":"41","author":"Janka","year":"2005","journal-title":"Hepatology"},{"key":"R12-22-20210210","doi-asserted-by":"crossref","first-page":"29198","DOI":"10.1074\/jbc.271.46.29198","article-title":"Identification and characterization of a leukocyte-specific component of the nuclear body.","volume":"271","author":"Bloch","year":"1996","journal-title":"J Biol Chem"},{"key":"R13-22-20210210","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0955-0674(94)90032-9","article-title":"The SNFSWI family of global transcriptional activators.","volume":"6","author":"Carlson","year":"1994","journal-title":"Curr Opin Cell Biol"},{"key":"R14-22-20210210","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1128\/MCB.19.6.4423","article-title":"Structural and functional heterogeneity of nuclear bodies.","volume":"19","author":"Bloch","year":"1999","journal-title":"Mol Cell Biol"},{"key":"R15-22-20210210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"American Association for Study of Liver Diseases. Primary biliary cirrhosis.","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"R16-22-20210210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2249.2004.02332.x","article-title":"True antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?","volume":"135","author":"Muratori","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"R17-22-20210210","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1053\/jhep.2002.34944","article-title":"American Association for the Study of Liver Disease. Diagnosis and treatment of autoimmune hepatitis.","volume":"36","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"R18-22-20210210","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1572-0241.1998.157_b.x","article-title":"Primary sclerosing cholangitis: a clinical review.","volume":"93","author":"Ponsioen","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R19-22-20210210","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#","article-title":"American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines.","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R20-22-20210210","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1158\/0008-5472.CAN-03-1199","article-title":"Restoration of promyelocytic leukemia protein-nuclear bodies in neuroblastoma cells enhances retinoic acid responsiveness.","volume":"64","author":"Yu","year":"2004","journal-title":"Cancer Res"},{"key":"R21-22-20210210","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","article-title":"Antibodies to SS-ARo-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.","volume":"26","author":"Granito","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R22-22-20210210","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis.","volume":"25","author":"Invernizzi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"R23-22-20210210","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.4049\/jimmunol.145.12.4338","article-title":"Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis.","volume":"145","author":"Szostecki","year":"1990","journal-title":"J Immunol"},{"key":"R24-22-20210210","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1080\/00365520310004876","article-title":"CM, Respaldiza N, Alvarez A et al. Clinical significance of anti-multiple nuclear dotsSp100 autoantibodies.","volume":"38","year":"2003","journal-title":"Scand J Gastroemterol"},{"key":"R25-22-20210210","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","article-title":"Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis.","volume":"98","author":"Muratori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R26-22-20210210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.2003.07270.x","article-title":"Positive markers in AMA-negative PBC.","volume":"98","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R27-22-20210210","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1111\/j.1572-0241.2004.40416.x","article-title":"WI, Crespo J, Pares A, et al., Spanish Group for the Study of Autoimmune Cholangitis. Serum immunological profile in patients with chronic autoimmune cholestasis.","volume":"99","author":"Romero-Gomez","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R28-22-20210210","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1073\/pnas.95.9.4991","article-title":"Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body.","volume":"95","author":"LaMorte","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R29-22-20210210","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/sj.onc.1204854","article-title":"Role and fate of PML nuclear bodies in response to interferon and viral infections.","volume":"20","year":"2001","journal-title":"Oncogene"},{"key":"R30-22-20210210","doi-asserted-by":"crossref","first-page":"11133","DOI":"10.1128\/JVI.76.21.11133-11138.2002","article-title":"Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1.","volume":"76","author":"Madani","year":"2002","journal-title":"J Virol"},{"key":"R31-22-20210210","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis.","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"R32-22-20210210","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1111\/j.1572-0241.2004.41121.x","article-title":"Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis.","volume":"99","author":"Kaplan","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R33-22-20210210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2006.06.002","article-title":"Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis.","volume":"27","author":"Rieger","year":"2006","journal-title":"J Autoimmun"},{"key":"R34-22-20210210","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0168-8278(01)00059-9","article-title":"Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope.","volume":"34","author":"Baum","year":"2001","journal-title":"J Hepatol"},{"key":"R35-22-20210210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0168-8278(01)00252-5","article-title":"Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis.","volume":"36","author":"Bogdanos","year":"2002","journal-title":"J Hepatol"},{"key":"R36-22-20210210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1053\/jhep.2001.21165","article-title":"Risk factors for primary biliary cirrhosis in a cohort of patients from the United States.","volume":"33","author":"Parikh-Patel","year":"2001","journal-title":"Hepatology"},{"key":"R37-22-20210210","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients.","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"R38-22-20210210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1590-8658(03)00466-3","article-title":"Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection.","volume":"35","author":"Bogdanos","year":"2003","journal-title":"Dig Liver Dis"},{"key":"R39-22-20210210","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0016-5085(03)00387-1","article-title":"Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis.","volume":"124","author":"Shimoda","year":"2003","journal-title":"Gastroenterology"},{"key":"R41-22-20210210","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaut.2008.05.003","article-title":"CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis.","volume":"31","author":"Shimoda","year":"2008","journal-title":"J Autoimmun"},{"key":"R42-22-20210210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-065X.1998.tb01220.x","article-title":"B-cell epitope spreading in autoimmunity.","volume":"164","author":"James","year":"1998","journal-title":"Immunol Rev"},{"key":"R43-22-20210210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy.","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R44-22-20210210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","article-title":"Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group.","volume":"41","author":"Vergani","year":"2004","journal-title":"J Hepatol"},{"key":"R45-22-20210210","first-page":"1123","article-title":"Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis.","volume":"26","author":"Zuchner","year":"1997","journal-title":"Hepatology"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg2009596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2009596","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg2009596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201001000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:28:35Z","timestamp":1786544915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201001000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2009.596","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}